CM
SIOX

Caption Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Caption Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-47,500
Closed -$134K – 1341
2020
Q2 		$134K Sell
47,500
-2,500
-5% -$8.02K ﹤0.01% 823
2020
Q1 		$122K Buy
50,000
+7,500
+18% +$27.1K 0.01% 752
2019
Q4 		$218K Buy
42,500
+7,700
+22% +$42.7K 0.01% 714
2019
Q3 		$225K Buy
+34,800
New +$240K 0.01% 577

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Caption Management's SIOX Position: Q1 2021 in Review

Caption Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2021, closing a stake of 45,000 shares — an estimated $125K sold.

Caption Management first reported a position in SIOX in Q3 2019 and held it in 4 quarters. The position peaked at $859K in Q3 2019. 56 funds tracked by Wall St. Rank hold SIOX as of Q1 2021.

  • Caption Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Caption Management sold 45,000 Sio Gene Therapies Inc. Common Stock shares in Q1 2021, an estimated $125K.
  • Caption Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • Caption Management's Sio Gene Therapies Inc. Common Stock position peaked at $859K in Q3 2019.
  • 56 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2021.

Based on Caption Management's 13F filing for Q1 2021, filed 17 May 2021.